Healthy Skepticism Library item: 627

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Frankel DH.
Servier criticised in perindopril campaign
Lancet 1996 Jan 20; 347:183

Keywords:
*news story Australia developed countries Servier perindopril ACE inhibitor quality of information company responses MaLAM Medical Lobby for Appropriate Marketing ETHICAL ISSUES IN PROMOTION: COMPANY STANDARDS EVALUATION OF PROMOTION: GENERAL QUALITY OF INFORMATION PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPED COUNTRIES REGULATION, CODES, GUIDELINES: FEEDBACK TO COMPANIES

Notes:

MaLAM and Servier have been conducing an ongoing debate as to the validity of Servier’s claims about its ACE inhibitor, perindopril.